The global biosimilar monoclonal antibody market was valued at $8.7 billion in 2022, and is projected to reach $64.7 billion by 2032, growing at a CAGR of 22.2% from 2023 to 2032.
Report Code : A03330 | Pages : 293 | Category : Life Sciences
The global immune checkpoint inhibitors market was valued at $40.1 billion in 2022, and is projected to reach $189.4 billion by 2032, growing at a CAGR of 16.8% from 2023 to 2032.
Report Code : A03382 | Pages : 248 | Category : Life Sciences
global over the counter (OTC) drugs & dietary supplements market was valued at $223 billion in 2016, and is expected to reach $335 billion by 2023, registering a ...
Report Code : A02362 | Pages : 220 | Category : Life Sciences
The global pneumonia vaccines market was valued at $7,083 million in 2017 and is expected to reach $10,215 million by 2025, growing at a CAGR of 5% from 2018 to 2025.
Report Code : A02397 | Pages : 171 | Category : Life Sciences
The global Gene Therapy Market Size was valued at $6.0 billion in 2020 and is projected to reach $46.5 billion by 2030, growing at a CAGR of 22.8% from 2021 to 2030.
Report Code : A02506 | Pages : 262 | Category : Life Sciences
The veterinary medicine market accounted for $22,973 million in 2019, and is expected to reach $29,698 million by 2027, registering a CAGR of 4.6% from 2020 to 2027.
Report Code : A03026 | Pages : 307 | Category : Life Sciences
Human chorionic gonadotropin (HCG) is a female hormone produced by the placenta after implantation of the egg, which is why it can be detected in a few pregnancy ...
Report Code : A03078 | Pages : 197 | Category : Life Sciences
The global psoriasis therapeutics market was valued at $22.9 billion in 2021, and is projected to reach $55.8 billion by 2031, growing at a CAGR of 9.3% from 2022 to 2031.
Report Code : A03405 | Pages : 242 | Category : Life Sciences
The global ulcerative colitis market was valued at $6.2 billion in 2020, and is projected to reach $10.8 billion by 2030, growing at a CAGR of 5.7% from 2021 to 2030.
Report Code : A03620 | Pages : 225 | Category : Life Sciences
The global generic drugs market was valued at $385.3 billion in 2022, and is projected to reach $835.7 billion by 2032, growing at a CAGR of 8.1% from 2023 to 2032.
Report Code : A03793 | Pages : 252 | Category : Life Sciences
The global vegetarian softgel capsules market size was valued at $527.28 million in 2020 and is projected to reach $824.39 million by 2030 registering a CAGR of 4.6% ...
Report Code : A03164 | Pages : 210 | Category : Life Sciences
The global cephalosporin market size was valued at $13.69 billion in 2019, and is estimated to reach $16.87 million by 2027, growing at a CAGR of 2.6% from 2019 to 2027.
Report Code : A03170 | Pages : 266 | Category : Life Sciences
The global gastrointestinal therapeutics market was valued at $39.5 billion in 2022, and is projected to reach $64.5 billion by 2032, growing at a CAGR of 5% from 2023 to 2032.
Report Code : A03195 | Pages : 320 | Category : Life Sciences
The global allergy treatment market was valued at $24,653.4 million in 2017 and is expected to reach $40,360.2 million by 2025, registering a CAGR of 6.3% from 2018 to 2025
Report Code : A03201 | Pages : 220 | Category : Life Sciences
The global diabetes therapeutics market was valued at $118,063.3 million in 2020 and is projected to reach $317,915 million by 2030, growing at a CAGR of 10.4% from ...
Report Code : A03202 | Pages : 160 | Category : Life Sciences
The global spirulina market was valued at $393.6 million in 2019, and is projected to reach $897.61 million by 2027, registering a CAGR of 10.5% from 2020 to 2027.
Report Code : A03875 | Pages : 246 | Category : Life Sciences
The global pharmaceutical glycerine market was valued at $89.89 million in 2020, and is projected to reach $246.48 million by 2030, growing at a CAGR of 11% from 2021 to 2030.
Report Code : A03973 | Pages : 180 | Category : Life Sciences
The global BCG vaccine market was valued at $46,637.5 thousands in 2020, and is projected to reach $74,269.55 thousands by 2030, registering a CAGR of 4.8% from 2021 to 2030.
Report Code : A04070 | Pages : 165 | Category : Life Sciences
The global aneurysmal subarachnoid hemorrhage drugs market was valued at $323.51 million in 2020, and is projected to reach $456.31 million by 2030, growing at a CAGR of 3.6% from 2021 to 2030.
Report Code : A04249 | Pages : 180 | Category : Life Sciences
The global narcolepsy drugs market size was valued at $2,680.06 million in 2020, and is projected to reach $6,667.80 million by 2030, registering a CAGR of 9.6% from ...
Report Code : A03272 | Pages : 198 | Category : Life Sciences
The global ocular drug delivery market was valued at $67.7 billion in 2022, and is projected to reach $115.5 billion by 2032, growing at a CAGR of 5.5% from 2023 to 2032.
Report Code : A03306 | Pages : 248 | Category : Life Sciences
The global PEGylated protein therapeutics market was valued at $10,388 million in 2017, and is estimated to reach at $17,813 million by 2025, registering a CAGR of 6.9% from 2018 to 2025.
Report Code : A03385 | Pages : 166 | Category : Life Sciences
The global rheumatoid arthritis drugs market size was valued at $57,929 million in 2019, and is projected to reach $62,935 million by 2027, registering a CAGR of 2.8% from 2020 to 2027.
Report Code : A03411 | Pages : 219 | Category : Life Sciences
Thyroid Gland Disorder Treatment Market is an endocrine gland that stimulates hormones, which help regulate the metabolism of the body. When the thyroid gland does not produce enough ...
Report Code : A03420 | Pages : 243 | Category : Life Sciences
The global topical pain relief market size was valued at $8,864.0 million in 2019, and is projected to reach $12,219.7 million by 2027 at a CAGR of 5.2% from 2020 to 2027.
Report Code : A04309 | Pages : 244 | Category : Life Sciences
